* Salarius Pharmaceuticals (NASDAQ:SLRX [https://seekingalpha.com/symbol/SLRX]) will implement a 1-for-15 reverse stock split effective August 15, 2025.
* The split aims to meet Nasdaq’s $1 minimum bid price requirement for continued listing.
* Outstanding shares will be reduced from ~7.6M to ~509,000.
* Source: Press release [https://seekingalpha.com/pr/20201039-salarius-pharmaceuticals-announces-1-forminus-15-reverse-stock-split]
MORE ON SALARIUS PHARMACEUTICALS
* Salarius Pharmaceuticals granted additional extension to regain Nasdaq compliance [https://seekingalpha.com/news/4467178-salarius-pharmaceuticals-granted-additional-extension-to-regain-nasdaq-compliance]
* Financial information for Salarius Pharmaceuticals [https://seekingalpha.com/symbol/SLRX/income-statement]
Salarius Pharmaceuticals announces 1-for-15 reverse stock split to regain Nasdaq compliance
Published 2 months ago
Aug 14, 2025 at 1:07 PM
Positive
Auto